HomeTBPH • NASDAQ
add
Theravance Biopharma Inc
Previous close
$8.40
Day range
$8.32 - $8.78
Year range
$7.44 - $10.90
Market cap
436.51M USD
Avg Volume
220.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 18.75M | 6.77% |
Operating expense | 18.50M | 16.73% |
Net income | -15.53M | -82.46% |
Net profit margin | -82.79 | -70.88% |
Earnings per share | -0.05 | -272.76% |
EBITDA | -8.78M | -41.47% |
Effective tax rate | -73.70% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.35M | -13.74% |
Total assets | 354.16M | -7.29% |
Total liabilities | 178.62M | 5.69% |
Total equity | 175.54M | — |
Shares outstanding | 49.47M | — |
Price to book | 2.37 | — |
Return on assets | -6.48% | — |
Return on capital | -10.09% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -15.53M | -82.46% |
Cash from operations | -902.00K | -5.62% |
Cash from investing | 15.69M | 2,416.99% |
Cash from financing | -365.00K | 98.81% |
Net change in cash | 14.42M | 144.86% |
Free cash flow | -44.50M | -1,155.74% |
About
Founded
2013
Website
Employees
97
